(1)
Weller, K.; Staubach, P.; Metz, M.; Chapman-Rothe, N.; Sieder, C.; Brautigam, M.; Maurer, M. Omalizumab Improves Angioedema-Related Quality of Life Impariment in Patients With Chronic Idiopathic/Chronic Spontaneous Urticaria: Results from the X-Act Study. J of Skin 2018, 2, S53.